| Protein | Taxonomy | omega-n-methylarginine (IC50) | staurosporine (IC50) |
|---|
| Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
| Chain B, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
| Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
| Chain A, Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0558 |
| Chain A, Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.012 |
| Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
| Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
| Chain X, Proto-oncogene tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0048 |
| Chain A, Serine/threonine-protein kinase TAO2 | Rattus norvegicus (Norway rat) | | 3 |
| epidermal growth factor receptor isoform a precursor | Homo sapiens (human) | | 0.4467 |
| Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | | 0.01 |
| Cell division cycle 7-related protein kinase | Homo sapiens (human) | | 0.0549 |
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | | 0.0083 |
| Serine/threonine-protein kinase 25 | Homo sapiens (human) | | 0.0029 |
| Citron Rho-interacting kinase | Homo sapiens (human) | | 0.749 |
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | | 0.9255 |
| Telomerase reverse transcriptase | Homo sapiens (human) | | 6.9517 |
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | | 0.1772 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | | 0.5561 |
| Aurora kinase A | Homo sapiens (human) | | 0.0087 |
| Cyclin-G-associated kinase | Homo sapiens (human) | | 0.011 |
| Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | | 0.267 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | | 0.1265 |
| Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | | 0.1161 |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | | 0.4137 |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | | 0.0072 |
| Death-associated protein kinase 3 | Homo sapiens (human) | | 0.0026 |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | | 0.0565 |
| Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.356 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Homo sapiens (human) | | 0.0231 |
| NUAK family SNF1-like kinase 1 | Homo sapiens (human) | | 0.003 |
| Cyclin-T1 | Homo sapiens (human) | | 0.0118 |
| Cyclin-T2 | Homo sapiens (human) | | 0.0038 |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | | 0.0016 |
| Rho-associated protein kinase 2 | Homo sapiens (human) | | 0.0045 |
| Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | | 0.0096 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | | 0.1246 |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | | 0.0011 |
| Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | | 0.0071 |
| Serine/threonine-protein kinase 16 | Homo sapiens (human) | | 0.2385 |
| Cyclin-K | Homo sapiens (human) | | 0.0948 |
| Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | | 0.0003 |
| Serine/threonine-protein kinase 17B | Homo sapiens (human) | | 0.0258 |
| Serine/threonine-protein kinase 10 | Homo sapiens (human) | | 0.008 |
| Serine/threonine-protein kinase D3 | Homo sapiens (human) | | 0.1446 |
| Cyclin-dependent kinase 14 | Homo sapiens (human) | | 0.1145 |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | | 0.0107 |
| Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | | 0.2829 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | | 0.0005 |
| Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | | 0.013 |
| Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | | 0.0132 |
| Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | | 0.0212 |
| G1/S-specific cyclin-E2 | Homo sapiens (human) | | 0.011 |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | | 0.0812 |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | | 0.1233 |
| Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | | 0.0063 |
| Epidermal growth factor receptor | Homo sapiens (human) | | 0.083 |
| RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | | 0.1281 |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | | 0.0713 |
| High affinity nerve growth factor receptor | Homo sapiens (human) | | 0.2403 |
| Protein kinase C gamma type | Homo sapiens (human) | | 0.1167 |
| Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | | 0.002 |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | | 0.2327 |
| Protein kinase C beta type | Homo sapiens (human) | | 0.0684 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | | 0.056 |
| Insulin receptor | Homo sapiens (human) | | 0.0706 |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | | 0.1784 |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0929 |
| Retinoblastoma-associated protein | Homo sapiens (human) | | 0.066 |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | | 0.0075 |
| Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | | 0.0039 |
| Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | | 0.1269 |
| Tyrosine-protein kinase Yes | Homo sapiens (human) | | 0.0029 |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0012 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | | 0.0021 |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | | 0.5534 |
| Hepatocyte growth factor receptor | Homo sapiens (human) | | 0.1917 |
| Tyrosine-protein kinase HCK | Homo sapiens (human) | | 0.0025 |
| Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | | 0.0004 |
| Protein kinase C delta type | Rattus norvegicus (Norway rat) | | 0.274 |
| Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | | 0.274 |
| Protein kinase C zeta type | Rattus norvegicus (Norway rat) | | 0.274 |
| Platelet-derived growth factor receptor beta | Homo sapiens (human) | | 0.3707 |
| Tyrosine-protein kinase Fgr | Homo sapiens (human) | | 0.0009 |
| Cytochrome P450 2D6 | Homo sapiens (human) | | 0.0002 |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | | 0.0412 |
| Breakpoint cluster region protein | Homo sapiens (human) | | 0.0945 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | | 0.059 |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | | 0.0216 |
| Fibroblast growth factor receptor 1 | Homo sapiens (human) | | 0.0699 |
| Cyclin-dependent kinase 1 | Mus musculus (house mouse) | | 0.008 |
| Cyclin-dependent kinase 4 | Homo sapiens (human) | | 0.0429 |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | | 0.3642 |
| Acyl-CoA desaturase 1 | Mus musculus (house mouse) | | 3.4 |
| Insulin receptor-related protein | Homo sapiens (human) | | 0.0113 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | | 0.0088 |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | | 0.003 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | | 4 |
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | | 0.0107 |
| Insulin receptor | Mus musculus (house mouse) | | 0.2 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | | 0.0004 |
| Platelet-derived growth factor receptor alpha | Homo sapiens (human) | | 0.0007 |
| Tyrosine-protein kinase Fer | Homo sapiens (human) | | 0.0008 |
| Protein kinase C alpha type | Homo sapiens (human) | | 0.0655 |
| cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | | 0.0115 |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | | 0.0149 |
| Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | | 0.011 |
| Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | | 0.1 |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | | 0.0025 |
| Casein kinase II subunit alpha' | Homo sapiens (human) | | 2.0215 |
| Cyclin-A2 | Homo sapiens (human) | | 0.009 |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | | 0.01 |
| Serine/threonine-protein kinase MAK | Homo sapiens (human) | | 0.0257 |
| Ephrin type-A receptor 1 | Homo sapiens (human) | | 0.0947 |
| Fibroblast growth factor receptor 2 | Homo sapiens (human) | | 0.0504 |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | | 0.0106 |
| Fibroblast growth factor receptor 4 | Homo sapiens (human) | | 0.17 |
| Fibroblast growth factor receptor 3 | Homo sapiens (human) | | 0.0554 |
| cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | | 0.0137 |
| Cyclin-O | Homo sapiens (human) | | 0.0015 |
| cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | | 0.0148 |
| Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | | 0.0007 |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | | 0.004 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | | 0.028 |
| G1/S-specific cyclin-D1 | Homo sapiens (human) | | 0.0355 |
| Protein kinase C eta type | Homo sapiens (human) | | 0.1165 |
| Cyclin-C | Homo sapiens (human) | | 0.0105 |
| G1/S-specific cyclin-E1 | Homo sapiens (human) | | 0.0108 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | | 0.0073 |
| Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | | 1.1595 |
| Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | | 0.002 |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | | 4.6724 |
| MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | | 0.0004 |
| cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | | 0.055 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | | 2.6853 |
| Ephrin type-A receptor 2 | Homo sapiens (human) | | 0.1257 |
| Ephrin type-A receptor 3 | Homo sapiens (human) | | 0.0347 |
| Ephrin type-A receptor 8 | Homo sapiens (human) | | 0.1061 |
| Ephrin type-B receptor 2 | Homo sapiens (human) | | 0.1191 |
| Leukocyte tyrosine kinase receptor | Homo sapiens (human) | | 0.0173 |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | | 0.0137 |
| G1/S-specific cyclin-D3 | Homo sapiens (human) | | 0.055 |
| Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | | 0.0131 |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | | 0.1848 |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | | 0.4119 |
| G protein-coupled receptor kinase 4 | Homo sapiens (human) | | 0.0914 |
| Kinesin-1 heavy chain | Homo sapiens (human) | | 0.0015 |
| G protein-coupled receptor kinase 5 | Homo sapiens (human) | | 0.0489 |
| Hexokinase-4 | Homo sapiens (human) | | 0.0006 |
| Beta-adrenergic receptor kinase 2 | Homo sapiens (human) | | 0.856 |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | | 0.0146 |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | | 0.1791 |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | | 0.026 |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | | 0.0014 |
| Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | | 4.288 |
| Activin receptor type-1B | Homo sapiens (human) | | 9.118 |
| TGF-beta receptor type-1 | Homo sapiens (human) | | 2.2823 |
| Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | | 0.85 |
| Tyrosine-protein kinase CSK | Homo sapiens (human) | | 0.2071 |
| Protein kinase C iota type | Homo sapiens (human) | | 0.1739 |
| Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | | 0.442 |
| Tyrosine-protein kinase Tec | Homo sapiens (human) | | 0.0338 |
| Tyrosine-protein kinase TXK | Homo sapiens (human) | | 0.0203 |
| Tyrosine-protein kinase ABL2 | Homo sapiens (human) | | 0.0505 |
| Tyrosine-protein kinase FRK | Homo sapiens (human) | | 0.0108 |
| G protein-coupled receptor kinase 6 | Homo sapiens (human) | | 0.0473 |
| Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0175 |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.0057 |
| Mitogen-activated protein kinase 8 | Homo sapiens (human) | | 1.1067 |
| Mitogen-activated protein kinase 9 | Homo sapiens (human) | | 2.0555 |
| Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | | 0.863 |
| Phosphorylase b kinase regulatory subunit alpha, liver isoform | Homo sapiens (human) | | 0.0005 |
| Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Homo sapiens (human) | | 0.0005 |
| Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | | 0.0099 |
| Casein kinase I isoform alpha | Homo sapiens (human) | | 3.412 |
| Casein kinase I isoform delta | Homo sapiens (human) | | 1.4 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | | 9 |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | | 0.735 |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | | 0.0105 |
| Casein kinase I isoform epsilon | Homo sapiens (human) | | 1.4 |
| Dual specificity protein kinase CLK1 | Homo sapiens (human) | | 0.0108 |
| Dual specificity protein kinase CLK2 | Homo sapiens (human) | | 0.6508 |
| Dual specificity protein kinase CLK3 | Homo sapiens (human) | | 0.92 |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | | 0.0103 |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | | 0.0435 |
| D(1A) dopamine receptor | Sus scrofa (pig) | | 0.001 |
| Cyclin-dependent kinase 7 | Homo sapiens (human) | | 0.2793 |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | | 0.0474 |
| Tyrosine-protein kinase Blk | Homo sapiens (human) | | 0.0011 |
| Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | | 0.0377 |
| Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | | 0.0002 |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | | 0.0046 |
| cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | | 0.0014 |
| Cyclin-H | Homo sapiens (human) | | 0.2793 |
| CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | | 0.1216 |
| Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | | 1.7683 |
| Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | | 0.0851 |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | | 0.0084 |
| Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | | 0.0036 |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | | 0.4397 |
| Death-associated protein kinase 1 | Homo sapiens (human) | | 0.0101 |
| LIM domain kinase 1 | Homo sapiens (human) | | 0.0026 |
| LIM domain kinase 2 | Homo sapiens (human) | | 0.0956 |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | | 0.4512 |
| Mitogen-activated protein kinase 10 | Homo sapiens (human) | | 0.0731 |
| 5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | | 1.1354 |
| Ephrin type-B receptor 3 | Homo sapiens (human) | | 1.2855 |
| Ephrin type-A receptor 5 | Homo sapiens (human) | | 0.0159 |
| Ephrin type-B receptor 4 | Homo sapiens (human) | | 0.1869 |
| Ephrin type-B receptor 1 | Homo sapiens (human) | | 0.0694 |
| Ephrin type-A receptor 4 | Homo sapiens (human) | | 0.0105 |
| Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | | 0.0009 |
| Calcium-dependent protein kinase 1 | Plasmodium falciparum K1 | | 0.24 |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | | 0.2168 |
| Casein kinase II subunit beta | Homo sapiens (human) | | 3.4 |
| Casein kinase II subunit alpha | Homo sapiens (human) | | 3.4723 |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | | 0.2029 |
| SRSF protein kinase 2 | Homo sapiens (human) | | 0.206 |
| Casein kinase I isoform gamma-2 | Homo sapiens (human) | | 1.9467 |
| Cyclin-A1 | Homo sapiens (human) | | 0.0013 |
| Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | | 0.0044 |
| MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | | 4 |
| Cyclin-dependent kinase 3 | Homo sapiens (human) | | 0.0118 |
| Cyclin-dependent kinase 6 | Homo sapiens (human) | | 0.0395 |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | | 0.0141 |
| Cyclin-dependent kinase 16 | Homo sapiens (human) | | 0.0206 |
| Cyclin-dependent kinase 17 | Homo sapiens (human) | | 0.0135 |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | | 0.048 |
| Protein kinase C epsilon type | Homo sapiens (human) | | 0.0767 |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | | 0.2314 |
| Angiopoietin-1 receptor | Homo sapiens (human) | | 0.0823 |
| Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | | 0.1952 |
| Protein kinase C theta type | Homo sapiens (human) | | 0.1168 |
| Activin receptor type-1 | Homo sapiens (human) | | 1.1354 |
| Macrophage-stimulating protein receptor | Homo sapiens (human) | | 0.2195 |
| Focal adhesion kinase 1 | Homo sapiens (human) | | 0.078 |
| Protein kinase C zeta type | Homo sapiens (human) | | 0.1722 |
| Protein kinase C delta type | Homo sapiens (human) | | 0.1283 |
| Tyrosine-protein kinase BTK | Homo sapiens (human) | | 0.0288 |
| Aldehyde oxidase | Homo sapiens (human) | | 0.0023 |
| Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | | 0.0177 |
| Cyclin-dependent kinase 18 | Homo sapiens (human) | | 0.0587 |
| Activated CDC42 kinase 1 | Homo sapiens (human) | | 0.0299 |
| Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | | 0.9655 |
| Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | | 0.0068 |
| Myotonin-protein kinase | Homo sapiens (human) | | 0.1735 |
| Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | | 0.0992 |
| Tyrosine-protein kinase Mer | Homo sapiens (human) | | 0.0331 |
| Serine/threonine-protein kinase 4 | Homo sapiens (human) | | 0.0013 |
| Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | | 0.0004 |
| Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | | 0.0252 |
| Mitogen-activated protein kinase 7 | Homo sapiens (human) | | 4.0032 |
| Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | | 0.0021 |
| Serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0034 |
| Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | | 0.438 |
| cGMP-dependent protein kinase 2 | Homo sapiens (human) | | 0.0161 |
| Rho-associated protein kinase 1 | Homo sapiens (human) | | 0.0038 |
| Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | | 0.0012 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | | 0.0018 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | | 0.0026 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | | 0.0024 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | | 0.0095 |
| Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | | 1.94 |
| Protein-tyrosine kinase 6 | Homo sapiens (human) | | 0.484 |
| cGMP-dependent protein kinase 1 | Homo sapiens (human) | | 0.0027 |
| Cyclin-dependent kinase 13 | Homo sapiens (human) | | 0.057 |
| Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | | 0.0032 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | | 0.0003 |
| Protein-tyrosine kinase 2-beta | Homo sapiens (human) | | 0.0095 |
| Maternal embryonic leucine zipper kinase | Homo sapiens (human) | | 0.0006 |
| Lysine--tRNA ligase | Homo sapiens (human) | | 0.0049 |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | | 0.0141 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | | 0.0005 |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | | 0.1448 |
| Serine/threonine-protein kinase 38 | Homo sapiens (human) | | 0.0037 |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | | 0.183 |
| Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | | 0.0002 |
| Ephrin type-A receptor 7 | Homo sapiens (human) | | 0.0477 |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0004 |
| Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | | 0.1995 |
| Myosin light chain kinase, smooth muscle | Homo sapiens (human) | | 0.0448 |
| TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 | Homo sapiens (human) | | 0.037 |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | | 1 |
| Serine/threonine-protein kinase STK11 | Homo sapiens (human) | | 0.0598 |
| Rhodopsin kinase GRK1 | Homo sapiens (human) | | 0.068 |
| Coiled-coil domain-containing protein 6 | Homo sapiens (human) | | 0.0022 |
| NT-3 growth factor receptor | Homo sapiens (human) | | 0.0002 |
| Serine/threonine-protein kinase N1 | Homo sapiens (human) | | 0.0025 |
| Serine/threonine-protein kinase N2 | Homo sapiens (human) | | 0.0055 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | | 0.5052 |
| Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | | 0.1475 |
| Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | | 0.016 |
| BDNF/NT-3 growth factors receptor | Homo sapiens (human) | | 0.0004 |
| MAP kinase-activated protein kinase 3 | Homo sapiens (human) | | 2.775 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | | 0.0017 |
| Discoidin domain-containing receptor 2 | Homo sapiens (human) | | 0.0008 |
| Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | | 0.0432 |
| Rho-associated protein kinase 2 | Bos taurus (cattle) | | 0.0417 |
| Myosin light chain kinase 3 | Homo sapiens (human) | | 0.1585 |
| Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | | 0.1464 |
| Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | | 0.0087 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0077 |
| Mitogen-activated protein kinase kinase kinase 21 | Homo sapiens (human) | | 1.1175 |
| Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | | 0.0032 |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | | 0.0067 |
| Testis-specific serine/threonine-protein kinase 1 | Mus musculus (house mouse) | | 0.0003 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | | 0.012 |
| Protein kinase C eta type | Rattus norvegicus (Norway rat) | | 0.274 |
| Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | | 0.0005 |
| Calcium/calmodulin-dependent protein kinase type 1B | Homo sapiens (human) | | 0.0044 |
| Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | | 0.0864 |
| Serine/threonine-protein kinase N3 | Homo sapiens (human) | | 0.0105 |
| Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | | 0.0027 |
| Kinase suppressor of Ras 2 | Homo sapiens (human) | | 5.4 |
| Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | | 0.0552 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | | 0.0416 |
| Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | | 0.0001 |
| Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | | 0.0008 |
| Serine/threonine-protein kinase Nek8 | Homo sapiens (human) | | 0.0263 |
| Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | | 0.0035 |
| Serine/threonine-protein kinase 32C | Homo sapiens (human) | | 0.232 |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | | 0.0001 |
| Myosin light chain kinase family member 4 | Homo sapiens (human) | | 0.0537 |
| Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | | 2.639 |
| Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | | 0.0003 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | | 0.0001 |
| Kinase suppressor of Ras 1 | Homo sapiens (human) | | 6.265 |
| Cyclin-dependent kinase-like 3 | Homo sapiens (human) | | 1.1 |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | | 0.212 |
| Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | | 0.0028 |
| Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | | 0.1102 |
| Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | | 0.0032 |
| Misshapen-like kinase 1 | Homo sapiens (human) | | 0.0004 |
| Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | | 0.089 |
| Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | | 0.0359 |
| Casein kinase I isoform alpha-like | Homo sapiens (human) | | 1.84 |
| Cyclin-Y | Homo sapiens (human) | | 0.0518 |
| Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | | 0.226 |
| Myosin-IIIa | Homo sapiens (human) | | 0.0425 |
| Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | | 0.521 |
| Protein odd-skipped-related 1 | Homo sapiens (human) | | 0.0402 |
| Mitogen-activated protein kinase 15 | Homo sapiens (human) | | 0.0081 |
| Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | | 0.101 |
| Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | | 0.0007 |
| Serine/threonine-protein kinase haspin | Homo sapiens (human) | | 0.0422 |
| Rhodopsin kinase GRK7 | Homo sapiens (human) | | 0.0053 |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | | 0.0107 |
| Myosin-IIIb | Homo sapiens (human) | | 0.0058 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | | 0.18 |
| Phosphorylase b kinase regulatory subunit beta | Homo sapiens (human) | | 0.0005 |
| Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | | 0.073 |
| Aurora kinase B | Homo sapiens (human) | | 0.007 |
| Lymphokine-activated killer T-cell-originated protein kinase | Homo sapiens (human) | | 0.0691 |
| MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | | 0.0001 |
| Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | | 0.0047 |
| Testis-specific serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0038 |
| Testis-specific serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0051 |
| Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | | 0.0122 |
| PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | | 0.0107 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | | 0.0246 |
| SRSF protein kinase 1 | Homo sapiens (human) | | 0.0337 |
| Mitogen-activated protein kinase kinase kinase 14 | Homo sapiens (human) | | 2.3 |
| Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | | 0.215 |
| Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | | 0.0092 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | | 0.0531 |
| Testis-specific serine/threonine-protein kinase 6 | Homo sapiens (human) | | 0.1525 |
| Serine/threonine-protein kinase 33 | Homo sapiens (human) | | 0.0374 |
| Serine/threonine-protein kinase D2 | Homo sapiens (human) | | 0.0014 |
| NUAK family SNF1-like kinase 2 | Homo sapiens (human) | | 0.0018 |
| Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | | 0.3669 |
| Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | | 0.0147 |
| STE20-like serine/threonine-protein kinase | Homo sapiens (human) | | 0.0142 |
| Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | | 0.0017 |
| Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | | 0.3655 |
| Tyrosine-protein kinase Srms | Homo sapiens (human) | | 6.5 |
| Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | | 0.456 |
| Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | | 0.203 |
| Inactive tyrosine-protein kinase PEAK1 | Homo sapiens (human) | | 0.0025 |
| Dual specificity protein kinase CLK4 | Homo sapiens (human) | | 0.0723 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0221 |
| Serine/threonine-protein kinase Sgk2 | Homo sapiens (human) | | 0.0159 |
| Casein kinase I isoform gamma-1 | Homo sapiens (human) | | 5.3367 |
| NADPH oxidase 4 | Homo sapiens (human) | | 0.0708 |
| Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | | 0.0327 |
| SNF-related serine/threonine-protein kinase | Homo sapiens (human) | | 0.0059 |
| Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | | 0.0062 |
| Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | | 0.0122 |
| Serine/threonine-protein kinase 32B | Homo sapiens (human) | | 0.0375 |
| Cyclin-dependent kinase 12 | Homo sapiens (human) | | 0.053 |
| Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | | 0.546 |
| Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | | 0.0003 |
| Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | | 0.0813 |
| Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | | 0.0039 |
| Serine/threonine-protein kinase 26 | Homo sapiens (human) | | 0.0124 |
| Serine/threonine-protein kinase NLK | Homo sapiens (human) | | 0.0666 |
| Ribosomal protein S6 kinase beta-2 | Homo sapiens (human) | | 0.0015 |
| Protein DBF4 homolog A | Homo sapiens (human) | | 0.0549 |
| Serine/threonine-protein kinase 17A | Homo sapiens (human) | | 0.0386 |
| STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | | 0.0158 |
| Ephrin type-A receptor 6 | Homo sapiens (human) | | 0.0161 |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | | 0.003 |
| Death-associated protein kinase 2 | Homo sapiens (human) | | 0.0064 |
| Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | | 0.0001 |
| TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | | 0.0103 |
| Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | | 0.0295 |
| Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | | 0.0076 |
| ALK tyrosine kinase receptor | Homo sapiens (human) | | 0.0044 |
| SRSF protein kinase 3 | Homo sapiens (human) | | 1.77 |
| Serine/threonine-protein kinase ICK | Homo sapiens (human) | | 0.0443 |
| Aurora kinase C | Homo sapiens (human) | | 0.0022 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | | 0.0024 |
| Protein kinase C theta type | Rattus norvegicus (Norway rat) | | 0.274 |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | | 0.3701 |
| Serine/threonine-protein kinase 38-like | Homo sapiens (human) | | 0.0012 |
| Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | | 0.1541 |
| Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | | 0.0335 |
| Serine/threonine-protein kinase WNK2 | Homo sapiens (human) | | 1.455 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | | 0.0017 |
| 5'-AMP-activated protein kinase subunit beta-1 | Homo sapiens (human) | | 1.1354 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | | 0.0002 |
| Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | | 0.0027 |
| Serine/threonine-protein kinase 24 | Homo sapiens (human) | | 0.0065 |
| Casein kinase I isoform gamma-3 | Homo sapiens (human) | | 2.675 |
| Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0003 |
| Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0013 |
| Authors | Studies |
|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Cho, KH; Dhorma, LP; Hah, JM; Kim, MH; Kim, SY; Kumar, DN; Park, HG; Venkanna, A | 1 |
| Craven, PA; DeRubertis, FR; Studer, RK | 1 |
| Chen, F; Demers, LM; Gaydos, LJ; Kuhn, DC; Sun, SC | 1 |
| Hirata, Y; Imai, T; Kanno, K; Marumo, F | 1 |
| MacDermot, J; McEwan, JR; Parsaee, H | 1 |
| Balakir, R; Hasty, K; Horton, WE; Precht, P; Udo, I | 1 |
| Barnhart, DC; Mulholland, MW; Sarosi, GA; Zhang, W | 1 |
| Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
| Chung, CK; Kim, HM; Oh, CH | 1 |
| Chang, YS; Dull, RO; Gardner, TW; Hillsley, MV; Jain, RK; Lakshminarayanan, S; Munn, LL; Tarbell, JM; Yuan, J | 1 |
| Hertkorn, C; Ischiropoulos, H; Mansfield, K; Shapiro, IM; Teixeira, CC | 1 |
| Article | Year |
|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Chemistry-oriented synthesis (ChOS) and target deconvolution on neuroprotective effect of a novel scaffold, oxaza spiroquinone.European journal of medicinal chemistry, 2019, Feb-01, Volume: 163Topics: Drug Discovery; Inflammation; Microglia; Neurodegenerative Diseases; Neuroprotective Agents; Nitric Oxide; Protein Kinase Inhibitors; Quinones; Spiro Compounds; Structure-Activity Relationship | 2019 |
Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response.The Journal of clinical investigation, 1994, Volume: 93, Issue:1
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alkaloids; Amino Acid Oxidoreductases; Animals; Arginine; Calcimycin; Carbachol; Cyclic GMP; Diabetes Mellitus, Experimental; Female; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Isoquinolines; Kidney Glomerulus; Kinetics; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phosphates; Phosphorylation; Piperazines; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Proteins; Rats; Rats, Sprague-Dawley; Staurosporine; Thromboxane A2 | 1994 |
Dependence and reversal of nitric oxide production on NF-kappa B in silica and lipopolysaccharide-induced macrophages.Biochemical and biophysical research communications, 1995, Sep-25, Volume: 214, Issue:3
Topics: Acetylcysteine; Alkaloids; Animals; Arginine; Base Sequence; Cell Line; Cell Nucleus; Enzyme Inhibitors; Indomethacin; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Molecular Sequence Data; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Oligonucleotide Probes; omega-N-Methylarginine; Protein Kinase C; Silicon Dioxide; Staurosporine; Tosylphenylalanyl Chloromethyl Ketone; Tyrosine | 1995 |
Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells.Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:1
Topics: Alkaloids; Amino Acid Oxidoreductases; Animals; Arginine; Base Sequence; Blotting, Northern; Calmodulin; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Induction; Interleukin-1; Molecular Sequence Data; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Polymerase Chain Reaction; Protein Kinase C; Rats; Recombinant Proteins; RNA, Messenger; Staurosporine; Sulfonamides | 1993 |
Bradykinin-induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine-sensitive kinase.British journal of pharmacology, 1993, Volume: 110, Issue:1
Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Aorta, Thoracic; Arginine; Bradykinin; Calcium; Cattle; Cell Line; Endothelium, Vascular; Epoprostenol; Ionomycin; Nitric Oxide; omega-N-Methylarginine; Phosphotransferases; Signal Transduction; Staurosporine | 1993 |
Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation.In vitro cellular & developmental biology. Animal, 1998, Volume: 34, Issue:5
Topics: Animals; Cell Line, Transformed; Chondrocytes; Cytokines; Enzyme Induction; Interleukin-1; Metalloendopeptidases; Nitric Oxide; omega-N-Methylarginine; Rats; Staurosporine; Tumor Necrosis Factor-alpha | 1998 |
Endothelin-stimulated capacitative calcium entry in enteric glial cells: synergistic effects of protein kinase C activity and nitric oxide.Journal of neurochemistry, 1998, Volume: 71, Issue:1
Topics: Alkaloids; Animals; Benzophenanthridines; Calcium; Calcium Channels; Carcinogens; Cells, Cultured; Drug Synergism; Endothelin-3; Enzyme Inhibitors; Guinea Pigs; Myenteric Plexus; Neuroglia; Nickel; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Penicillamine; Phenanthridines; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate | 1998 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.Circulation, 1999, Feb-16, Volume: 99, Issue:6
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
Activation of inducible nitric oxide synthase by Taraxacum officinale in mouse peritoneal macrophages.General pharmacology, 1999, Volume: 32, Issue:6
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Interferon-gamma; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Plant Extracts; Plants, Medicinal; Protein Kinase C; Staurosporine; Tumor Necrosis Factor-alpha | 1999 |
Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.Microvascular research, 2000, Volume: 59, Issue:2
Topics: Animals; Aorta; Body Water; Bradykinin; Capillary Permeability; Cattle; Cells, Cultured; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Infant, Newborn; Lymphokines; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Penicillamine; Protein Kinase C; Retina; Serum Albumin; Staurosporine; Tetradecanoylphorbol Acetate; Thrombin; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Phosphate-induced chondrocyte apoptosis is linked to nitric oxide generation.American journal of physiology. Cell physiology, 2001, Volume: 281, Issue:3
Topics: Animals; Apoptosis; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Cells, Cultured; Chick Embryo; Chondrocytes; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Glutathione; Growth Plate; Intracellular Membranes; Membrane Potentials; Mitochondria; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroso Compounds; omega-N-Methylarginine; Platelet Aggregation Inhibitors; S-Nitrosoglutathione; Staurosporine | 2001 |